-
-
-
-
-
-
-
Erste Group Downgrades Amgen (AMGN) to Hold
-
-
-
-
-
-
-
AstraZeneca, Amgen partner with FDA to test real-time AI trial monitoring
-
-
-
-
-
-
-
Stifel on Viridian (VRDN): 'We view positive REVEAL-2 chronic TED data in 2Q26 as important'
-
-
-
-
-
-
-
FDA: 'The agency today is withdrawing final guidance titled “Scientific Considerations in Demonstrating Biosimilarity to a Reference Product'
-
-
-
-
-
-
-
Freedom Capital Markets Downgrades Amgen (AMGN) to Hold (mid morning)
-
-
-
-
-
-
-
Amgen (AMGN) Tops Q4 EPS by 56c, Beats on Revenue; Offers FY26 Guidance
-
-
-
-
-
-
-
Bernstein SocGen Group Downgrades Amgen (AMGN) to Market Perform
-
413,572 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

